Résultats de la recherche - Anita K. Wagner
- Résultat(s) 1 - 9 résultats de 9
-
1
30 years of media coverage on high drug prices in the US - a never-ending story or a time for change? par Christine Leopold, James D Chambers, Anita K Wagner
Publié 2015Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
2
Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand par Christine Leopold, Christine Y. Lu, Anita K. Wagner
Publié 2020Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
3
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway par Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner
Publié 2024Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
4
1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities par Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan
Publié 2020Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
5
The Brazilian private pharmaceutical market after the first ten years of the generics law par Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan
Publié 2019Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
6
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context par Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan
Publié 2024Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
7
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context par Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci
Publié 2023Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
8
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries par Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Publié 2014Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre -
9
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China par Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD
Publié 2013Cote: Chargement en cours…Connect to this object online.
Localisé: Chargement en cours…
Livre